Host controlled restriction mutants of Staphylococcus aureus.

S. Iordanescu

Abstract:

What problem does this paper attempt to address?

Fetal Growth Restriction: Does an Integrated Maternal Hemodynamic-Placental Model Fit Better?

F. Mecacci,L. Avagliano,F. Lisi,S. Clemenza,Caterina Serena,S. Vannuccini,M. P. Rambaldi,S. Simeone,S. Ottanelli,F. Petraglia

DOI: https://doi.org/10.1007/s43032-020-00393-2

2020-11-19

Reproductive Sciences

Abstract:Abstract In recent years, a growing interest has arisen regarding the possible relationship between adverse pregnancy outcomes (APOs) and inadequate maternal hemodynamic adaptations to the pregnancy. A possible association between “placental syndromes,” such as preeclampsia (PE) and fetal growth restriction (FGR), and subsequent maternal cardiovascular diseases (CVD) later in life has been reported. The two subtypes of FGR show different pathogenetic and clinical features. Defective placentation, due to a poor trophoblastic invasion of the maternal spiral arteries, is believed to play a central role in the pathogenesis of early-onset PE and FGR. Since placental functioning is dependent on the maternal cardiovascular system, a pre-existent or subsequent cardiovascular impairment may play a key role in the pathogenesis of early-onset FGR. Late FGR does not seem to be determined by a primary abnormal placentation in the first trimester. The pathological pathway of late-onset FGR may be due to a primary maternal cardiovascular maladaptation: CV system shows a flat profile and remains similar to those of non-pregnant women. Since the second trimester, when the placenta is already developed and increases its functional request, a hypovolemic state could lead to placental hypoperfusion and to an altered maturation of the placental villous tree and therefore to an altered fetal growth. Thus, this review focalizes on the possible relationship between maternal cardiac function and placentation in the development of both early and late-onset FGR. A better understanding of maternal hemodynamics in pregnancies complicated by FGR could bring various benefits in clinical practice, improving screening and therapeutic tools.

obstetrics & gynecology,reproductive biology
Maternal cardiovascular function at mid‐gestation is related to placental angiogenesis

I. Papastefanou,A. Szczepkowska,M. Tezhaeva,M. De Pauli,M. Charakida,K. H. Nicolaides

DOI: https://doi.org/10.1002/uog.27616

2024-02-15

Ultrasound in Obstetrics and Gynecology

Abstract:Objective To investigate whether placental function, reflected in the levels of angiogenic factors, is associated with maternal cardiac function and hemodynamic responses at 19 to 24 weeks' gestation after adjustment for maternal risk factors and pregnancy complications. Methods Prospective study on women with singleton pregnancies attending Kings' College Hospital, London, UK for a routine hospital visit at 19‐24 weeks' gestation. We recorded maternal characteristics and measured mean arterial pressure, maternal heart rate, serum placental growth factor and soluble fms‐like tyrosine kinase 1 (sFLT‐1). We also performed maternal echocardiogram to assess cardiac output and peripheral vascular resistance as well as indices of diastolic and systolic function. Results Our cohort included 4006 women. Lower placental growth factor (PlGF) values were significantly associated with higher mean arterial pressure (MAP) (p<0.001), lower maternal heart rate (p<0.001), lower mitral valve s' velocity (p= 0.027) and higher left atrial volume (p=0.022) after adjustment for maternal characteristics and pregnancy complications. sFLT‐1 was positively related to relative wall thickness (p= 0.012), whereas sFLT‐1/ PlGF ratio was negatively associated with mitral valve A (p= 0.006) and positively associated with left atrial volume (p= 0.015) and MAP (p= 0.004). The magnitude of these associations was similar in the subgroup of women without any risk factors from their obstetric and medical history. Conclusion A continuous link of moderate strength between angiogenic factors and subclinical maternal cardiac function alterations is present at mid‐gestation, independently of preexisting maternal risk factors and pregnancy complications. Impaired placental function appears to be related to a mild systolic and diastolic dysfunction and cardiac remodeling. This article is protected by copyright. All rights reserved.

radiology, nuclear medicine & medical imaging,obstetrics & gynecology,acoustics
Placental Findings in Pregnancies Complicated by Maternal Cardiovascular Disease

Fred M Wu,Bradley J Quade,Chrystalle Katte Carreon,Zoë J Schefter,Abigail Moses,Cara L Lachtrupp,John C Markley,Kimberlee Gauvreau,Anne Marie Valente,Katherine E Economy,STORCC Investigators,Shivani R Aggarwal,Nael Aldweib,Laith Alshawabkeh,Nancy Barker,Yonatan Buber,Jean Marie Carabuena,Matthew Carazo,Emily Dollar,Sheila Drakeley,Valeria Duarte,Sarah Rae Easter,Gabriele Egidy Assenza,Julia Graf,Michelle Gurvitz,Daniel Halpern,Amy Harmon,Kelsey Hickey,Jenna Hynes,Caitlyn Joyce,William P Knapp,Michael Landzberg,Roisin Morgan,Mary Mullen,Alexander Opotowsky,Sara Partington,Dorothy Pearson,Saraubh Rajpal,Carla P Rodriguez-Monserrate,Carrie Rouse,Keri Shafer,Michael N Singh,Ada C Stefanescu Schmidt,Allison L Tsao,Shailendra Upadhyay

DOI: https://doi.org/10.1016/j.jacadv.2022.100008

2022-03-16

Abstract:Background: The incidence of pregnancy in women with cardiovascular disease (CVD) has increased, yet little is known about placental pathology in these women. Objectives: The objectives of this study were to describe placental pathology in pregnancies complicated by maternal CVD and to compare findings among categories of maternal CVD. Methods: A retrospective, single-center study was conducted. Pathology reports for 264 placentas from pregnancies complicated by maternal CVD were reviewed for prespecified pathologic findings which were then compared against maternal characteristics. Results: Placentas were from pregnancies associated with maternal congenital heart disease (n = 171), arrhythmia (n = 43), cardiomyopathy (n = 20), connective tissue disease (n = 20), and valvular heart disease (n = 10). Median maternal age at delivery was 32 years (range: 19-49). Median gestational age at delivery was 39 weeks (range: 25-41). Placental pathology was identified in 75% (199/264) of placentas. Anatomic pathology, primarily small placenta by weight, was present in 45% (119/264) of placentas. Vascular pathology, primarily maternal vascular malperfusion or fetal vascular malperfusion, was seen in 41% (107/264) of placentas. Acute chorioamnionitis and villitis of unknown etiology (VUE) were seen in 23% (61/264) and 11% (28/264) of placentas, respectively. Prevalence of VUE differed across CVD categories (P = 0.008) and was most common in maternal congenital heart disease; there were no differences in anatomic, infectious, and vascular pathologies across CVD categories. Conclusions: Pregnancies among women with CVD commonly demonstrate abnormal placental findings, especially anatomic and vascular pathology. Prevalence of VUE differed across CVD categories. Otherwise, the incidence of specific pathology findings did not differ based on maternal characteristics.
Cardiac physiology and pathophysiology in pregnancy

Shekoofeh Saboktakin Rizi,Evan Wiens,Jennifer Hunt,Robin Ducas

DOI: https://doi.org/10.1139/cjpp-2024-0010

2024-08-31

Canadian Journal of Physiology and Pharmacology

Abstract:Canadian Journal of Physiology and Pharmacology, Ahead of Print. Cardiovascular disease is the leading indirect cause of maternal morbidity and mortality, accounting for nearly one third of maternal deaths during pregnancy. The burden of cardiovascular disease in pregnancy is increasing, as are the incidence of maternal morbidity and mortality. Normal physiologic adaptations to pregnancy, including increased cardiac output and plasma volume, may unmask cardiac conditions, exacerbate previously existing conditions, or create de novo complications. It is important for care providers to understand the normal physiologic changes of pregnancy and how they may impact the care of patients with cardiovascular disease. This review outlines the physiologic adaptions during pregnancy and their pathologic implications for some of the more common cardiovascular conditions in pregnancy.

pharmacology & pharmacy,physiology
Placental vascular malperfusion lesions in fetal congenital heart disease

Rachel L Leon,Kavita Sharma,Imran N Mir,Christina L Herrera,Steven L Brown,Catherine Y Spong,Lina F Chalak

DOI: https://doi.org/10.1016/j.ajog.2022.05.038

Abstract:Background: Fetuses with congenital heart disease are at increased risk of perinatal morbidity and mortality, which is highly influenced by their prenatal health. Placental function is vital for the health of the fetus, but increased rates of pathologic lesions of the placenta have been observed in pregnancies complicated by fetal congenital heart disease. Objective: This study aimed to determine the prevalence of both gross and histologic placental pathologies in a cohort of pregnancies complicated by fetal congenital heart disease vs healthy controls using the Amsterdam Placental Workshop Group Consensus Statement sampling and definitions of placental lesions. Study design: This single-center retrospective cohort study included placental examinations from pregnancies diagnosed prenatally with fetal congenital heart disease between 2010 and 2019; moreover, control placentas were collected from pregnancies without maternal or fetal complications. Placentas were sampled and evaluated according to the Amsterdam Placental Workshop Group Consensus Statement and gross and histopathologic diagnoses determined. Results: Approximately 80% of fetuses diagnosed with congenital heart disease (n=305) had a placental examination for comparison with controls (n=40). Of note, 239 placentas (78%) in the group with fetal congenital heart disease had at least 1 gross or histopathologic lesion compared with 11 placentas (28%) in the control group (P<.01). One-third of placentas complicated by fetal congenital heart disease met the criteria for small for gestational age, and 48% of placentas had one or more chronic lesions, including maternal vascular malperfusion (23% vs 0%; P<.01), villitis of unknown etiology (22% vs 0%; P<.01), fetal vascular malperfusion (20% vs 0%; P<.01), and other chronic lesions (16% vs 0%; P<.01). Acute inflammation was equally present in both the group with fetal congenital heart disease and the control group (28% vs 28%; P=1.00). Although gestational age and birthweight z score were similar between the 2 groups, birth head circumference was 1.5 cm less in pregnancies complicated by fetal congenital heart disease with a significantly lower z score compared with the control group (-0.52±1.22 vs 0.06±0.69; P<.01). Conclusion: Vascular malperfusion lesions and chronic forms of inflammation occur at markedly higher rates in placentas complicated by fetal congenital heart disease, which may contribute to the decreased head circumference at birth. Further work in neuroplacentology is needed to explore connections among cardiac defects, placental vascular malperfusion lesions, and fetal brain development.
Gender differences in patients with coronary artery disease in Japan: the Japanese Coronary Artery Disease Study (the JCAD study).

H. Kambara,T. Yamazaki,Doubun Hayashi,T. Kohro,Yoshihiro Okada,R. Nagai

DOI: https://doi.org/10.1253/circj.CJ-08-0252

2009-03-11

Circulation Journal

Abstract:BACKGROUND Gender differences among patients with coronary artery disease vary from study to study. In one of the largest studies, the Japanese Coronary Artery Disease (JCAD) Study, gender differences in patients were investigated. METHODS AND RESULTS Consecutive patients diagnosed with stenosis 75% or more in at least one branch of the coronary arteries were enrolled in the study. The endpoint is a composite of all-cause death and cardiovascular events. Data were collected over the internet. Out of 15,628 patients screened, 13,812 of them met the inclusion criteria and were followed up for a mean period of 2.7 years. The event rate was 62.8 per 1,000 patients-year, all-cause death 17.3 and total cardiac events 47.4. The incident rate of unstable angina was higher in females (27.1) than males (21.8) (P=0.0363). The incidence of all-cause death was lower in females than males (16.9 and 17.8, respectively; P=0.0148). Other than gender, hypertension and number of vessel disease contribute to the event of unstable angina, and age, family history, obesity, impaired fasting glycemia, hyperlipidemia, congestive heart failure and number of vessel disease contribute to the all-cause death. CONCLUSIONS Gender is an independent contributing factor of unstable angina and of all-cause death.
Near to One's Heart: The Intimate Relationship Between the Placenta and Fetal Heart

Emily J. Camm,Kimberley J. Botting,Amanda N. Sferruzzi-Perri

DOI: https://doi.org/10.3389/fphys.2018.00629

IF: 4

2018-06-26

Frontiers in Physiology

Abstract:The development of the fetal heart is exquisitely controlled by a multitude of factors, ranging from humoral to mechanical forces. The gatekeeper regulating many of these factors is the placenta, an external fetal organ. As such, resistance within the placental vascular bed has a direct influence on the fetal circulation and therefore, the developing heart. In addition, the placenta serves as the interface between the mother and fetus, controlling substrate exchange and release of hormones into both circulations. The intricate relationship between the placenta and fetal heart is appreciated in instances of clinical placental pathology. Abnormal umbilical cord insertion is associated with congenital heart defects. Likewise, twin-to-twin transfusion syndrome, where monochorionic twins have unequal sharing of their placenta due to inter-twin vascular anastomoses, can result in cardiac remodeling and dysfunction in both fetuses. Moreover, epidemiological studies have suggested a link between placental phenotypic traits and increased risk of cardiovascular disease in adult life. To date, the mechanistic basis of the relationships between the placenta, fetal heart development and later risk of cardiac dysfunction have not been fully elucidated. However, studies using environmental exposures and gene manipulations in experimental animals are providing insights into the pathways involved. Likewise, surgical instrumentation of the maternal and fetal circulations in large animal species has enabled the manipulation of specific humoral and mechanical factors to investigate their roles in fetal cardiac development. This review will focus on such studies and what is known to date about the link between the placenta and heart development.

physiology
Long-Term Consequences of Placental Vascular Pathology on the Maternal and Offspring Cardiovascular Systems

Marisa Benagiano,Salvatore Mancuso,Jan J. Brosens,Giuseppe Benagiano

DOI: https://doi.org/10.3390/biom11111625

IF: 6.064

2021-11-03

Biomolecules

Abstract:Over the last thirty years, evidence has been accumulating that Hypertensive Disorders of Pregnancy (HDP) and, specifically, Preeclampsia (PE) produce not only long-term effects on the pregnant woman, but have also lasting consequences for the fetus. At the core of these consequences is the phenomenon known as defective deep placentation, being present in virtually every major obstetrical syndrome. The profound placental vascular lesions characteristic of this pathology can induce long-term adverse consequences for the pregnant woman’s entire arterial system. In addition, placental growth restriction and function can, in turn, cause a decreased blood supply to the fetus, with long-lasting effects. Women with a history of HDP have an increased risk of Cardiovascular Diseases (CVD) compared with women with normal pregnancies. Specifically, these subjects are at a future higher risk of: Hypertension; Coronary artery disease; Heart failure; Peripheral vascular disease; Cerebrovascular accidents (Stroke); CVD-related mortality. Vascular pathology in pregnancy and CVD may share a common etiology and may have common risk factors, which are unmasked by the “stress” of pregnancy. It is also possible that the future occurrence of a CVD may be the consequence of endothelial dysfunction generated by pregnancy-induced hypertension that persists after delivery. Although biochemical and biophysical markers of PE abound, information on markers for a comparative evaluation in the various groups is still lacking. Long-term consequences for the fetus are an integral part of the theory of a fetal origin of a number of adult diseases, known as the Barker hypothesis. Indeed, intrauterine malnutrition and fetal growth restriction represent significant risk factors for the development of chronic hypertension, diabetes, stroke and death from coronary artery disease in adults. Other factors will also influence the development later in life of hypertension, coronary and myocardial disease; they include parental genetic disposition, epigenetic modifications, endothelial dysfunction, concurrent intrauterine exposures, and the lifestyle of the affected individual.

biochemistry & molecular biology
Cardiogenic Shock and Utilization of Mechanical Circulatory Support in Pregnancy

Anna C. O’Kelly,Amy Sarma,Emily Naoum,Sarah Rae Easter,Katherine Economy,Jonathan Ludmir

DOI: https://doi.org/10.1177/08850666231225606

2024-01-13

Journal of Intensive Care Medicine

Abstract:Journal of Intensive Care Medicine, Ahead of Print. Maternal mortality rates are rising in the United States, a trend which is in contrast to that seen in other high-income nations. Cardiovascular disease and hypertensive disorders of pregnancy are consistently the leading causes of maternal mortality both in the United States and globally, accounting for about one-quarter to one-third of maternal and peripartum deaths. A large proportion of cardiovascular morbidity and mortality stems from acquired disease in the context of cardiovascular risk factors, which include obesity, pre-existing diabetes and hypertension, and inequities in care from maternal care deserts and structural racism. Patients may also become pregnant with preexisting structural heart disease, or acquire disease throughout pregnancy (ex: spontaneous coronary artery dissection, peripartum cardiomyopathy), and be at higher risk of pregnancy-related cardiovascular complications. While risk-stratification tools including the modified World Health Organization (mWHO) classification, Cardiac Disease in Pregnancy (CARPREG II) and Zwangerschap bij Aangeboren HARtAfwijking/Pregnancy in Women with Congenital Heart Disease (ZAHARA) have been designed to help physicians identify patients at increased risk for adverse pregnancy outcomes and who may therefore benefit from referral to a tertiary care center, the limitation of these scores is their predominant focus on patients with known preexisting heart disease. As such, identifying patients at risk for pregnancy complications presents a significant challenge, and it is often patients with high-risk cardiovascular substrates prior to or during pregnancy who are at a highest risk for adverse pregnancy outcomes including cardiogenic shock.

critical care medicine
Cardiovascular health in early pregnancy and circulating biomarkers of placental health and function

Andrea C Kozai,Bethany Barone Gibbs,Samuel Parry,Sadiya S Khan,William Grobman,Lisa D Levine,Rebecca McNeil,David M Haas,Jessica L Pippen,Robert M Silver,Janet M Catov

DOI: https://doi.org/10.1101/2024.08.16.24312132

2024-08-17

Abstract:Background Maternal cardiovascular health (CVH) and placental health are related to pregnancy outcomes, yet how early pregnancy CVH affects placentation is not well characterized. The objective of this study was to determine associations between CVH and concentrations of placental proteins. Methods Participants from the nuMoM2b prospective cohort were included (n=2188). Maternal CVH was defined three ways: (1) composite scores using 6 components measured in the 1st trimester (four behavioral components of physical activity, diet, sleep duration, and smoking, and the health factors of blood pressure and body mass index); (2) latent classes of the four behavioral components; and (3) individual health behaviors. Linear regression associated composite CVH, latent classes, and individual health behaviors with 1st and 2nd trimester circulating markers of placental growth and development (pregnancy-associated plasma protein A, PAPP-A), pro-angiogenic (vascular endothelial growth factor, VEGF; placental growth factor, PlGF), and anti-angiogenic factors (soluble FMS-like tyrosine kinase 1, sFlt-1; soluble endoglin, sEng). Results and Conclusions More favorable composite CVH was associated with higher PAPP-A (representing better 1st trimester placental growth and development) and lower VEGF and higher sEng (representing an anti-angiogenic 1st trimester profile). Higher levels of physical activity were associated with lower 2nd trimester PAPP-A and higher 1st trimester VEGF and lower sFlt-1 (pro-angiogenic). In the four groups identified with latent class analysis (Healthy Behaviors, Active with Poor Diet, Inactive with Poor Diet, and Less Healthy Behaviors), first trimester sFlt-1 was lower in the Healthy Behaviors group compared to Inactive with Poor Diet group. Modifiable aspects of CVH in early pregnancy are related to placental health and function and may be useful targets for intervention.
Maternal heart failure: state-of-the-art review

Usman S. Najam,Jitae A. Kim,Sophie Y. Kim,Gurleen Wander,Mario Rodriguez,Hafeez Ul Hassan Virk,Mark R. Johnson,W. H. Wilson Tang,Chayakrit Krittanawong

DOI: https://doi.org/10.1007/s10741-024-10466-y

2024-11-16

Heart Failure Reviews

Abstract:Pregnancy is a period of substantial changes to the body's normal physiology, and the failure to adapt to these changes can lead to life-threatening pathology, particularly involving the cardiovascular system. In comparison to pre-pregnancy physiology, pregnant women have increased blood volume and physical demands which exert increased stress on the heart. This is important to consider in women with and without previously diagnosed cardiovascular disease, as the physiologic changes during pregnancy and postpartum can lead to sudden decompensation. The management of heart failure is particularly important as it remains the most common cardiovascular complication during pregnancy and is associated with substantial maternal and fetal morbidity and mortality. This is especially true in patients with pre-existing heart failure, who should receive counseling before conception and in certain cases be advised against pregnancy. For these reasons, healthcare professionals must be well-versed in the different strategies of diagnosis, management, treatment, and monitoring. This review will outline the pathophysiology, diagnostics, management, and general approach to heart failure in pregnant patients.

cardiac & cardiovascular systems
Maternal heart exhibits metabolic and redox adaptations post-uncomplicated pregnancy

Carolina Tocantins,João D Martins,Óscar M Rodrigues,Luís F Grilo,Mariana S Diniz,Jelena Stevanovic-Silva,Jorge Beleza,Pedro Coxito,David Rizo-Roca,Estela Santos-Alves,António J Moreno,António Ascensão,José Magalhães,Paulo J Oliveira,Susana P Pereira

DOI: https://doi.org/10.1016/j.bbadis.2024.167539

Abstract:Pregnancy may be a challenging period for the maternal systems and has been regarded as a stress test, as imperceptible/mild dysfunctions eventually present may be exacerbated during this period. The cardiovascular system is no exception, and several morphological and functional adaptations accompanying pregnancy have been described. However, long-term pregnancy-induced cardiac molecular alterations remain highly unexplored. The postpartum is marked by reverse remodeling of the pregnancy-induced cardiovascular adaptations, representing a possible critical period for assessing future maternal cardiovascular health. The current study explored the molecular and metabolic alterations in the cardiac tissue eight weeks after a physiological uncomplicated pregnancy. Female Sprague-Dawley rats were fed a chow diet through pregnancy, lactation, and weaning and compared to their non-pregnant counterparts. Eight weeks postpartum, increased levels of the phosphorylated form of AMPKα (Thr172) and its ratio to total AMPKα indicated possible alterations in cardiac metabolic flexibility, accompanied by increased Pparα and Hif1α transcripts levels. Additionally, postpartum hearts exhibited higher mitochondrial ATP and NADH levels without major changes in mitochondrial respiratory function. Elevated Nrf2 levels in the cardiac tissue suggested potential implications for cardiac redox balance, further supported by increased levels or activity of proteins directly regulated by Nrf2. The findings herein reported suggest that at eight weeks postpartum, molecular alterations induced by pregnancy, especially regarding redox balance, are still observed in the mothers' heart. These alterations present at late postpartum may open new avenues to understand the different risk for cardiovascular complications development after normal pregnancies.
Preliminary data on short-term outcomes within the cardio-obstetrics registry

D S Siry,I H Hoerbrand,A C H Haney,N F Frey,P E Ehlermann,J B Beckendorf

DOI: https://doi.org/10.1093/eurheartj/ehae666.3099

IF: 39.3

2024-10-30

European Heart Journal

Abstract:Background Pregnancy leads to physiological changes within the cardiovascular system such as increased plasma volume and cardiac output or hypercoagulability. These changes can be challenging for women with pre-existing cardiovascular disease with higher risks of complications. The guidelines of the European Society of Cardiology recommend treating high-risk patients in specialized centres by an interdisciplinary pregnancy heart team. In a team-based approach, the Pregnancy Heart Team was founded at our university hospital, in order to establish specific structures of communication and responsibility. Methods A prospective registry of all patients treated by the Pregnancy Heart Team between November 2022 and March 2024 was established. Patients consisted of women with pre-existing cardiovascular disease undergoing pregnancy as well as women who developed pregnancy-associated cardiovascular disease. Patients were evaluated throughout pregnancy by lab work and echocardiography during each trimester as well as in the postpartum period. Results In total 39 women (mean age 34±5 years) were prospectively included in the registry. 17 patients (43.5%) were classified as mWHO ≥ III. 17 patients (43.5 %) with pre-existing (pregnancy-associated) cardiovascular disease were managed throughout pregnancy and delivery. 9 patients (18.4 %) developed pregnancy-associated cardiovascular diseases such as peripartum cardiomyopathy or spontaneous coronary artery dissection. Preliminary data shows that mean left-ventricular ejection fraction remained stable during pregnancy with a non-significant trend towards lower values postpartum. Cardiac biomarkers such as high-sensitivity troponin T and NT-pro-BNP showed a non-significant trend towards increased values in the third trimester and postpartum. Adverse maternal outcomes occurred in 14 patients (35.9 %), including preterm premature rupture of membranes (12.2%), gestational hypertension (7.6%), gestational diabetes (5.1%), preeclampsia/eclampsia (7.6%) and delivery-associated complications (10.2%). Fetal complications included macrosomia (10.2%) or intrauterine growth retardation (5.1%). Discussion These preliminary data of a real-world patient collectivedemonstrate that a significant number of patients experienced adverse pregnancy outcomes which was associated with a trend towards increased cardiac biomarkers throughout pregnancy and postpartum. As recent studies have shown, interpretation of standard parameters such as cardiac biomarkers is not fully understood during pregnancy, especially in women with pre-existing cardiovascular disease. Our data may aid to understand prognostic implications of cardiac biomarkers during pregnancy.

cardiac & cardiovascular systems
Pregnancy in women with congenital heart disease: a focus on management and preventing the risk of complications

Gurleen Wander,Johanna A. van der Zande,Roshni R Patel,Mark R Johnson,Jolien Roos-Hesselink

DOI: https://doi.org/10.1080/14779072.2023.2237886

2023-07-22

Expert Review of Cardiovascular Therapy

Abstract:Congenital heart disease (CHD) is the most common cardiac disorder in pregnancy in the western world (around 80%). Due to improvements in surgical interventions more women with CHD are surviving to adulthood and choosing to become pregnant. Preconception counseling, antenatal management of CHDs and strategies to prevent maternal and fetal complications. Preconception counseling should start early, before the transition to adult care and be offered to both men and women. It should include the choice of contraception, lifestyle modifications, pre-pregnancy optimization of cardiac state, the chance of the child inheriting a similar cardiac lesion, the risks to the mother, and long-term prognosis. Pregnancy induces marked physiological changes in the cardiovascular system that may precipitate cardiac complications. Risk stratification is based on the underlying cardiac disease and data from studies including CARPREG, ZAHARA, and ROPAC. Women with left to right shunts, regurgitant lesions, and most corrected CHDs are at lower risk and can be managed in secondary care. Complex CHD, including systemic right ventricle need expert counseling in a tertiary center. Those with severe stenotic lesions, pulmonary artery hypertension, and Eisenmenger's syndrome should avoid pregnancy, be given effective contraception and managed in a tertiary center if pregnancy does happen.
Interdependence of placenta and fetal cardiac development

Rachel L. Leon,Lynn Bitar,Vidya Rajagopalan,Catherine Y. Spong

DOI: https://doi.org/10.1002/pd.6572

2024-04-29

Prenatal Diagnosis

Abstract:The placenta and fetal heart undergo development concurrently during early pregnancy, and, while human studies have reported associations between placental abnormalities and congenital heart disease (CHD), the nature of this relationship remains incompletely understood. Evidence from animal studies suggests a plausible cause and effect connection between placental abnormalities and fetal CHD. Biomechanical models demonstrate the influence of mechanical forces on cardiac development, whereas genetic models highlight the role of confined placental mutations that can cause some forms of CHD. Similar definitive studies in humans are lacking; however, placental pathologies such as maternal and fetal vascular malperfusion and chronic deciduitis are frequently observed in pregnancies complicated by CHD. Moreover, maternal conditions such as diabetes and pre‐eclampsia, which affect placental function, are associated with increased risk of CHD in offspring. Bridging the gap between animal models and human studies is crucial to understanding how placental abnormalities may contribute to human fetal CHD. The next steps will require new methodologies and multidisciplinary approaches combining innovative imaging modalities, comprehensive genomic testing, and histopathology. These studies may eventually lead to preventative strategies for some forms of CHD by targeting placental influences on fetal heart development.

genetics & heredity,obstetrics & gynecology
Outcome of Pregnancy Complicated with Cardiac Disease: a Review of 455 Patients

王妍,杨孜,张龑,赵扬玉,李诗兰,叶蓉华,魏媛,王永清,江元慧

DOI: https://doi.org/10.3969/j.issn.1672-1861.2009.06.009

2009-01-01

Abstract:Objective Objective To investigate the effect of different cardiac function of pregnancy complicated with cardiac disease on the outcome of pregnant women and newborn.Methods Clinical data of 455 pregnant patients complicated with cardiac disease were reviewed.Results The most common cardiac disease during pregnancy was arrhythmias with the NYHA grading Ⅰ~Ⅱ(49.01%),followed were congenital heart disease and rheumatic heart disease,with a frequency of 30.77% and 7.25%,respectively.Five of the congenital heart disease were of grade Ⅲ~Ⅳ,and one mother with Eisenmenger syndrome died one week postpartum with irreversible hypoxia.Seventeen patients developed heart failure complicated with preeclampsia-eclampsia,one of them died after cesarean section.The average neonate body weight of the patients with NYHA grading Ⅰ~Ⅱ was significantly higher than that of the patients with NYHA grading Ⅲ and Ⅳ(P0.05).The incidence of perinatal mortality and medical preterm delivery were higher in women with Grading Ⅲ~Ⅳ than in those with Grading Ⅰ~Ⅱ(P0.01).Conclusions The chief causes of NYHA grading Ⅲ~Ⅳ during pregnancy were preeclampsia-eclampsia with heart failure,congenital heart disease and peripartum cardiomyopathy,which resulted in the increasing of medical preterm delivery,maternal and preinatal mortality.
Autonomic Dysfunction and Cardiac Performance in Pregnant Women with Hypertensive Disorders: A Comparative Study Using Heart Rate Variability and Global Longitudinal Strain

Carina Bogdan,Adrian Apostol,Viviana Mihaela Ivan,Oana Elena Sandu,Ion Petre,Izabella Petre,Luciana-Elena Marc,Felix-Mihai Maralescu,Daniel Florin Lighezan

DOI: https://doi.org/10.3390/life14081039

2024-08-21

Life

Abstract:(1) Background: Pregnancy induces significant physiological adaptations with substantial impacts on the cardiovascular system. Hypertensive disorders of pregnancy (HDPs) are connected to significant risks of maternal and fetal complications, contributing significantly to morbidity and mortality across the globe. This study focuses on evaluating autonomic dysfunction by analyzing heart rate variability (HRV) and assessing cardiac performance through global longitudinal strain (GLS) using speckle tracking echocardiography, as well as examining diastolic function in pregnant women with HDP compared to healthy pregnant controls. (2) Methods: A case–control study was conducted involving pregnant women diagnosed with gestational hypertension (GH), preeclampsia (PE), or severe preeclampsia (SPE) as the case group, and healthy pregnant women as the control group. HRV was measured to evaluate autonomic function, GLS was assessed using speckle tracking echocardiography, and diastolic function was evaluated through standard echocardiographic parameters. Data were analyzed to compare cardiac performance and autonomic regulation between the HDP and control group, as well as among the different HDP subgroups. (3) Results: The HDP group exhibited significantly reduced HRV parameters compared to healthy controls, indicating notable autonomic dysfunction. Speckle tracking echocardiography revealed lower GLS among women with HDP, particularly in those with SPE, compared to the control group. Diastolic dysfunction was also present in the HDP group. (4) Conclusions: HRV and GLS are valuable non-invasive tools for detecting autonomic dysfunction and cardiac performance impairments in pregnant women with hypertensive disorders. These findings suggest that autonomic and cardiac dysfunctions are prevalent in HDP.

biology
Placental histopathology in sickle cell disease: A descriptive and hypothesis-generating study

Ann Kinga Malinowski,Claudia Dziegielewski,Sarah Keating,Tony Parks,John Kingdom,Nadine Shehata,Elyssa Rizov,Rohan D'Souza

DOI: https://doi.org/10.1016/j.placenta.2020.04.003

IF: 3.287

Placenta

Abstract:Introduction: Abnormal placental development is a unifying factor amongst many adverse pregnancy outcomes (APOs) in Sickle Cell Disease (SCD). Our aim was to describe placental histopathologic findings in women with SCD and their relationship with APOs, and to explore the association between antenatal sonographic findings and placental pathology. Methods: Retrospective single-centre case series of all pregnant women with SCD (January 2000-December 2017), pregnancy beyond 20 weeks' gestation, and available placenta histopathology. APOs included intrauterine fetal death, early neonatal death, preterm birth, small for gestational age, and hypertensive disorders of pregnancy. Review of images for mid-pregnancy ultrasound and one proximal to delivery was completed, blinded to clinical outcomes and histopathology results. Gross and histopathologic findings were reviewed and characterized per published classification. Results: Of 72 placentas, abnormalities were present in 69%, with Maternal Vascular Malperfusion (MVM) noted in 40%. APOs were encountered in 61% overall and in 79% of those with MVM. Neither SCD genotype nor severe maternal anemia had an influence on histopathologic placental features. Presence of high-resistance uterine artery waveforms at mid-trimester ultrasound was strongly associated with APOs and with abnormal findings on placental histopathology, most notably MVM. MVM was strongly associated with small for gestational age infants, preterm birth, and stillbirth. Discussion: MVM is the predominant lesion in placentas of women with SCD and is strongly associated with APOs. Mid-trimester ultrasound can identify a subset of women at risk. Future research into advanced imaging modalities to aid in antenatal diagnosis alongside investigations of potentially beneficial therapies is needed.
Placental hypoxia-induced alterations in vascular function, morphology, and endothelial barrier integrity

Philippe Vangrieken,Alex H. V. Remels,Salwan Al-Nasiry,Aalt Bast,Ger. M. J. Janssen,Ulrike von Rango,Daan Vroomans,Yannick C. W. Pinckers,Frederik J. van Schooten,Paul M. H. Schiffers

DOI: https://doi.org/10.1038/s41440-020-0528-8

2020-07-30

Hypertension Research

Abstract:Preeclampsia (PE) is a pregnancy-related disorder characterized by hypertension and proteinuria that affects 3–10% of all pregnancies. Although its pathophysiology remains obscure, placental hypoxia-induced oxidative stress and alterations in vascular function, morphology, and endothelial barrier integrity are considered to play a key role in the development of preeclampsia. In this study, placental villous explants of noncomplicated placentae and BeWo cells were subjected to hypoxia. The effect of placental hypoxic-conditioned medium (HCM) on intraluminal-induced contraction and endothelial barrier integrity in chorionic arteries was investigated using pressure myography. The impact of BeWo cell HCM on endothelial cell viability, reactive oxygen species formation and inflammation was also determined. Alterations in arterial morphology and contractile responsiveness to the thromboxane A2 analog (U46619) after exposure to placental HCM were examined immunohistochemically and by wire myography, respectively. Intraluminal administration of placental HCM induced vasoconstriction and increased the endothelial permeability for KCl, which was concentration-dependently prevented by quercetin. Placental and BeWo cell HCMs decreased endothelial cell viability, increased the production of reactive oxygen species and enhanced the secretion of IL-6 and IL-8. The cross-sectional area of the arterial media was increased upon exposure to placental HCM, which was associated with increased vascular proliferation and contractile responsiveness to U46619, and all of these effects were prevented by the antioxidants quercetin and RRR-α-tocopherol. This study is the first to comprehensively demonstrate the link between factors secreted by placental cells in response to hypoxia and vascular abnormalities and paves the way for new diagnostic approaches and therapies to better protect the maternal vasculature during and after a preeclampsia-complicated pregnancy.

peripheral vascular disease
Multidisciplinary care of peripartum heart failure: A scientific statement of the Heart Failure Association of the ESC

Amina Rakisheva,Karen Sliwa,Johann Bauersachs,Sophie Van Linthout,Vijay K. Chopra,Antoni Bayes‐Genis,Franca Fruzzetti,Antonio Cannatà,Benjamin Deniau,Alexandre Mebazaa,Gianluigi Savarese,Robin Ray,Cristiana Vitale,Marco Metra,Giuseppe M.C. Rosano

DOI: https://doi.org/10.1002/ejhf.3246

2024-04-30

European Journal of Heart Failure

Abstract:Heart failure is the most common cardiovascular complication during pregnancy and the postpartum period. It is associated with increased risk of maternal morbidity and mortality as well as potentially life‐threatening foetal pathology. Management of heart failure in pregnancy requires expert knowledge of cardiovascular disease as well as obstetrics which underscores the importance of multidisciplinary cardio‐obstetrics teams in order to optimize diagnosis, treatment and outcome. This includes counselling of women at risk before and during the course of pregnancy in order to strengthen the relationship between medical specialists and patients, as well as to allow patient‐centred delivery of care and improve quality of life.

cardiac & cardiovascular systems

Host controlled restriction mutants of Staphylococcus aureus.

Fetal Growth Restriction: Does an Integrated Maternal Hemodynamic-Placental Model Fit Better?

Maternal cardiovascular function at mid‐gestation is related to placental angiogenesis

Placental Findings in Pregnancies Complicated by Maternal Cardiovascular Disease

Cardiac physiology and pathophysiology in pregnancy

Placental vascular malperfusion lesions in fetal congenital heart disease

Gender differences in patients with coronary artery disease in Japan: the Japanese Coronary Artery Disease Study (the JCAD study).

Near to One's Heart: The Intimate Relationship Between the Placenta and Fetal Heart

Long-Term Consequences of Placental Vascular Pathology on the Maternal and Offspring Cardiovascular Systems

Cardiogenic Shock and Utilization of Mechanical Circulatory Support in Pregnancy

Cardiovascular health in early pregnancy and circulating biomarkers of placental health and function

Maternal heart failure: state-of-the-art review

Maternal heart exhibits metabolic and redox adaptations post-uncomplicated pregnancy

Preliminary data on short-term outcomes within the cardio-obstetrics registry

Pregnancy in women with congenital heart disease: a focus on management and preventing the risk of complications

Interdependence of placenta and fetal cardiac development

Outcome of Pregnancy Complicated with Cardiac Disease: a Review of 455 Patients

Autonomic Dysfunction and Cardiac Performance in Pregnant Women with Hypertensive Disorders: A Comparative Study Using Heart Rate Variability and Global Longitudinal Strain

Placental histopathology in sickle cell disease: A descriptive and hypothesis-generating study

Placental hypoxia-induced alterations in vascular function, morphology, and endothelial barrier integrity

Multidisciplinary care of peripartum heart failure: A scientific statement of the Heart Failure Association of the ESC